SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001785530-22-000038
Filing Date
2022-11-10
Accepted
2022-11-10 07:07:41
Documents
69
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q howl-20220930.htm   iXBRL 10-Q 1753306
2 EX-31.1 a09302022ex311.htm EX-31.1 9641
3 EX-31.2 a09302022ex312.htm EX-31.2 9662
4 EX-32.1 a09302022ex321.htm EX-32.1 7183
  Complete submission text file 0001785530-22-000038.txt   6412535

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT howl-20220930.xsd EX-101.SCH 38138
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT howl-20220930_cal.xml EX-101.CAL 52609
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT howl-20220930_def.xml EX-101.DEF 223214
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT howl-20220930_lab.xml EX-101.LAB 502389
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT howl-20220930_pre.xml EX-101.PRE 353467
63 EXTRACTED XBRL INSTANCE DOCUMENT howl-20220930_htm.xml XML 920213
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40366 | Film No.: 221374896
SIC: 2834 Pharmaceutical Preparations